Cited by 65Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchProtease and Inhibitor Mechanisms

The metalloprotease ADAMTS4 generates N-truncated Aβ4–x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer’s disease

Open access
Walter, Susanne, Jumpertz, Thorsten, Hüttenrauch, Melanie, Ogorek, Isabella, Gerber, Hermeto, Storck, Steffen E., Zampar, Silvia, Dimitrov, Mitko +10 more·2019·Acta Neuropathologica

Abstract

Brain accumulation and aggregation of amyloid-β (Aβ) peptides is a critical step in the pathogenesis of Alzheimer's disease (AD). Full-length Aβ peptides (mainly Aβ1-40 and Aβ1-42) are produced through sequential proteolytic cleavage of the amyloid precursor protein (APP) by β- and γ-secretases. However, studies of autopsy brain samples from AD patients have demonstrated that a large fraction of insoluble Aβ peptides are truncated at the N-terminus, with Aβ4-x peptides being particularly abundant. Aβ4-x peptides are highly aggregation prone, but their origin and any proteases involved in their generation are unknown. We have identified a recognition site for the secreted metalloprotease ADAMTS4 (a disintegrin and metalloproteinase with thrombospondin motifs 4) in the Aβ peptide sequence, which facilitates Aβ4-x peptide generation. Inducible overexpression of ADAMTS4 in HEK293 cells resulted in the secretion of Aβ4-40 but unchanged levels of Aβ1-x peptides. In the 5xFAD mouse model of amyloidosis, Aβ4-x peptides were present not only in amyloid plaque cores and vessel walls, but also in white matter structures co-localized with axonal APP. In the ADAMTS4-/- knockout background, Aβ4-40 levels were reduced confirming a pivotal role of ADAMTS4 in vivo. Surprisingly, in the adult murine brain, ADAMTS4 was exclusively expressed in oligodendrocytes. Cultured oligodendrocytes secreted a variety of Aβ species, but Aβ4-40 peptides were absent in cultures derived from ADAMTS4-/- mice indicating that the enzyme was essential for Aβ4-x production in this cell type. These findings establish an enzymatic mechanism for the generation of Aβ4-x peptides. They further identify oligodendrocytes as a source of these highly amyloidogenic Aβ peptides.

Integrity signals

Registry

Crossref · 10.1007/s00401-018-1929-5

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 84 · Cited by 65

Authors
Walter, S., Jumpertz, T., Hüttenrauch, M., Ogorek, I., Gerber, H., Storck, S. E., Zampar, S., Dimitrov, M., Lehmann, S., Lepka, K., Berndt, C., Wiltfang, J., Becker-Pauly, C., Beher, D., Pietrzik, C. U., Fraering, P. C., Wirths, O., & Weggen, S.
Affiliations
  • Heinrich Heine University Düsseldorf (DE)
  • University of Göttingen (DE)
  • University of Fribourg (CH)
  • Johannes Gutenberg University Mainz (DE)
  • École Polytechnique Fédérale de Lausanne (CH)
  • Asceneuron (Switzerland) (CH)
  • European Organization for Nuclear Research (CH)
Corresponding author
  • Wirths, Oliver
  • Weggen, Sascha
Venue
Acta Neuropathologica
Published
2018-11-13
Volume
137
Issue
2
Pages
239-257
ISSN
  • 0001-6322 (ISSN-L)
  • 1432-0533
OpenAlex
W2901207656
Cited by
65
References
84
Citations by year
2026: 6 · 2025: 8 · 2024: 7 · 2023: 10 · 2022: 5 · 2021: 18 · 2020: 7 · 2019: 4
FWCI
4.97
Type
journal article
Language
en
Open access
Licence
Locations
  • Acta Neuropathologica (publishedVersion)
  • PubMed (publishedVersion)
  • reroDoc Digital Library (submittedVersion)
  • Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
Funders
  • Stiftung VERUM
  • Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf (9772513)
  • Alzheimer Forschung Initiative (16013)
  • Foundation Eclosion
  • Foundation Strauss
  • Foundation SFNTF
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Keywords
ADAMTS-4, amyloid-beta, oligodendrocytes, Alzheimer's disease, amyloid precursor protein, metalloproteinases, proteolytic cleavage, amyloid plaques, white matter, 5xFAD mice, amyloidogenic peptides
MeSH terms
ADAMTS4 Protein, Alzheimer Disease, Animals, Brain, Disease Models, Animal, Humans, Oligodendroglia, Peptide Fragments, Amyloid beta-Peptides, Mice, Amyloid Precursor Protein Secretases, HEK293 Cells, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review